Cloverfields Capital Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.53M Buy
63,123
+1,354
+2% +$121K 1.98% 11
2026
Q1
$4.44M Sell
61,769
-804
-1% -$61.9K 1.44% 31
2025
Q4
$4.97M Buy
62,573
+5,723
+10% +$451K 1.54% 28
2025
Q3
$4.29M Buy
56,850
+104
+0.2% +$7.13K 1.34% 31
2025
Q2
$3.91M Buy
56,746
+11,621
+26% +$762K 1.16% 37
2025
Q1
$3.06M Buy
+45,125
New +$2.7M 1.01% 41

Other funds holding CVS

Cloverfields Capital Group's CVS Position: Q2 2026 in Review

Cloverfields Capital Group increased its CVS Health (CVS) stake by 2.2% in Q2 2026, buying an estimated $121K and bringing the position to 63,123 shares worth $6.53M. The position accounts for 1.98% of the portfolio, ranked #11.

Cloverfields Capital Group first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cloverfields Capital Group held 63,123 shares of CVS Health worth $6.53M as of Q2 2026.
  • Cloverfields Capital Group bought 1,354 CVS Health shares in Q2 2026, an estimated $121K.
  • CVS Health made up 1.98% of Cloverfields Capital Group's portfolio in Q2 2026, its #11 holding.
  • Cloverfields Capital Group first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cloverfields Capital Group's 13F filing for Q2 2026, filed 13 Aug 2026.